Milestone Pharmaceuticals Inc. (NASDAQ: MIST) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT MILESTONE PHARMACEUTICALS INC.

Milestone Pharmaceuticals Inc. (NASDAQ: MIST)
Listen to this Section


$2.02
+0.0250 ( +0.75% ) 232.7K

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Market Data


Open $2.02
Previous Close $1.99
Volume 232.7K
Market Cap $107.19M
Day Range $2.01 - $2.10
52 Week Range $1.12 - $2.75
Shares Outstanding 53.33M
Change % +0.75%
Net Change ▲ 0.0250
Insider Ownership -0.03%
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology: Pharmaceutical Preparations
IPO Year 2019
Country Canada
Under Writer IPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -160,000.00

Date Type Amount Purchased Purchaser
2024-07-17 Sale -80000.00 Duty Stuart
2024-07-17 Sale -80000.00 Saik Andrew

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 16 Feb 26, 2024
sc Insider transactions 1 Feb 14, 2024
sc Insider transactions 1 Feb 14, 2024
sc Insider transactions 1 Feb 09, 2024

Latest News


× Before browsing our site, please accept our cookies policy